ID: ALA4206883

Max Phase: Preclinical

Molecular Formula: C9H12N2O2S

Molecular Weight: 212.27

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccc2c(c1)N(C)CNS2(=O)=O

Standard InChI:  InChI=1S/C9H12N2O2S/c1-7-3-4-9-8(5-7)11(2)6-10-14(9,12)13/h3-5,10H,6H2,1-2H3

Standard InChI Key:  SRAKAVGHDQXMIS-UHFFFAOYSA-N

Associated Targets(Human)

Glutamate receptor ionotropic, AMPA 2 847 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 212.27Molecular Weight (Monoisotopic): 212.0619AlogP: 0.68#Rotatable Bonds: 0
Polar Surface Area: 49.41Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.60CX Basic pKa: CX LogP: 1.36CX LogD: 1.36
Aromatic Rings: 1Heavy Atoms: 14QED Weighted: 0.69Np Likeness Score: -0.97

References

1. Drapier T, Geubelle P, Bouckaert C, Nielsen L, Laulumaa S, Goffin E, Dilly S, Francotte P, Hanson J, Pochet L, Kastrup JS, Pirotte B..  (2018)  Enhancing Action of Positive Allosteric Modulators through the Design of Dimeric Compounds.,  61  (12): [PMID:29775064] [10.1021/acs.jmedchem.8b00250]

Source